We are committed to making a meaningful impact on patients' lives.
Our mission is to develop transformative medicines for orphan diseases of the kidney.
- Life-threatening Genetic Disease
- 4th Leading Cause of Kidney Failure
- Limited Treatment Options
- Learn More
- Lixivaptan in Development for PKD
- Learn More
Please visit our website again for updates on ELISA, our upcoming Phase 2 clinical study in patients with Autosomal Dominant Polycystic Kidney Disease.